Financial News
Atara Biotherap (NQ: ATRA )
7.600
+0.540
(+7.65%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 30, 2024
Add to My Watchlist
Press Releases about Atara Biotherap
![](https://mms.businesswire.com/media/20230918233480/en/792504/22/Atara-Bio1_logo_300x185-1.jpg)
![](https://mms.businesswire.com/media/20230919197771/en/792504/22/Atara-Bio1_logo_300x185-1.jpg)
![](https://mms.businesswire.com/media/20230830304194/en/792504/22/Atara-Bio1_logo_300x185-1.jpg)
![](https://mms.businesswire.com/media/20230823714878/en/792504/22/Atara-Bio1_logo_300x185-1.jpg)
![](https://mms.businesswire.com/media/20230808955684/en/792504/22/Atara-Bio1_logo_300x185-1.jpg)
![](https://mms.businesswire.com/media/20230727317663/en/792504/22/Atara-Bio1_logo_300x185-1.jpg)
![](https://mms.businesswire.com/media/20230728015130/en/792504/22/Atara-Bio1_logo_300x185-1.jpg)
![](https://mms.businesswire.com/media/20230728481682/en/792504/22/Atara-Bio1_logo_300x185-1.jpg)
![](https://mms.businesswire.com/media/20230626863928/en/792504/22/Atara-Bio1_logo_300x185-1.jpg)
![](https://mms.businesswire.com/media/20230605005907/en/792504/22/Atara-Bio1_logo_300x185-1.jpg)
![](https://mms.businesswire.com/media/20230602005342/en/792504/22/Atara-Bio1_logo_300x185-1.jpg)
![](https://mms.businesswire.com/media/20230602005023/en/792504/22/Atara-Bio1_logo_300x185-1.jpg)
![](https://mms.businesswire.com/media/20230508005577/en/792504/22/Atara-Bio1_logo_300x185-1.jpg)
![](https://mms.businesswire.com/media/20230501005702/en/792504/22/Atara-Bio1_logo_300x185-1.jpg)
![](https://mms.businesswire.com/media/20230424005664/en/792504/22/Atara-Bio1_logo_300x185-1.jpg)
![](https://mms.businesswire.com/media/20230329005956/en/792504/22/Atara-Bio1_logo_300x185-1.jpg)
![](https://mms.businesswire.com/media/20230302005714/en/792504/22/Atara-Bio1_logo_300x185-1.jpg)
![](https://mms.businesswire.com/media/20230227005833/en/792504/22/Atara-Bio1_logo_300x185-1.jpg)
![](https://mms.businesswire.com/media/20230221005734/en/792504/22/Atara-Bio1_logo_300x185-1.jpg)
![](https://mms.businesswire.com/media/20230208005851/en/792504/22/Atara-Bio1_logo_300x185-1.jpg)
![](https://mms.businesswire.com/media/20230207006101/en/1707786/5/MicrosoftTeams-image_%286%29.jpg)
![](https://www.businesswire.com/images/bwlogo_extreme.png)
![](https://mms.businesswire.com/media/20230203005031/en/792504/22/Atara-Bio1_logo_300x185-1.jpg)
![](https://mms.businesswire.com/media/20230113005443/en/792504/22/Atara-Bio1_logo_300x185-1.jpg)
![](https://mms.businesswire.com/media/20230104005704/en/792504/22/Atara-Bio1_logo_300x185-1.jpg)
![](https://mms.businesswire.com/media/20221218005048/en/792504/22/Atara-Bio1_logo_300x185-1.jpg)
![](https://mms.businesswire.com/media/20221218005056/en/792504/22/Atara-Bio1_logo_300x185-1.jpg)
Atara Biotherapeutics Announces Changes to Its Board of Directors
December 19, 2022
Via Business Wire
![](https://mms.businesswire.com/media/20221218005055/en/792504/22/Atara-Bio1_logo_300x185-1.jpg)
![](https://mms.businesswire.com/media/20221213006114/en/792504/22/Atara-Bio1_logo_300x185-1.jpg)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.